Supplementary Information
In addition to the "Material and Methods" section, the Supplementary Information contains Figures S1-S7 with legends. The figures illustrate a CAD MS/MS spectrum of the phosphopeptide comprising residues 57-71 ( Fig.S1 ), ECD MS/MS spectra of Arg28 and Arg49 containing phospho-peptides ( Fig.S2 ), major groove interactions undergone by the HTH motif of CtsR (Fig.S3 ), substrate preference of McsB (Fig.S4 ), the 31 P NMR spectra of different phosphopeptides (Fig.S5) , the thermal stability of peptidic phospho-arginine ( Fig.S6 ), a comparison of McsB and eukaryotic phosphagen kinases (Fig.S7) , and a representative part of the experimental electron density (Fig.S8 ).
MATERIAL AND METHODS

Cloning, expression and purification of CtsR and McsB
Full length CtsR containing a hexa-histidine tag was used for structure-function studies. The expression construct generated by PCR amplification of the ctsR gene from Bacillus stearothermophilus (B. stearothermophilus (Donk) NCA 26 [ATCC 12980]) using oligonucleotides with the sequence GATGATCATATGCCGAACATTTCCGACATCATTG and TGATCTCGAGTTTGTATTTCAGCGACGTCAGCAT (restriction sites underlined) was cleaved with NdeI and XhoI, and cloned into the pET21a expression vector (Stratagene). To prepare selenomethionine-substituted CtsR, the protein was expressed in the methionine auxotrophic E. coli cell line B834 that carries a mutation in metB impairing methionine biosynthesis. Cells were harvested by centrifugation, resuspended in 500 mM NaCl, 50 mM KH 2 PO 4 pH 7.5 and disrupted by sonication. The cleared lysate was loaded on a Ni 2+ -nitrilotriacetate column (NiNTA) and CtsR was eluted by applying a step-wise imidazol gradient. Further purification was achieved by size exclusion chromatography (SEC) using a Superdex-200 column (GE Healthcare) equilibrated with 500 mM KCl, 2 mM DTT, 15 mM KH 2 PO 4 pH 7.5. The postulated dimeric assembly of CtsR was confirmed by analytical SEC and dynamic light scattering. CtsR mutants that were subject to binding and phosphorylation studies were generated using either the QuikChange II (for single mutations) or the QuikChange Multi (for multiple mutations) site-directed mutagenesis kit (Stratagene). All mutant constructs were verified by DNA sequence analysis. Purification of the CtsR mutants followed the same 2-step procedure combining NiNTA chromatography and SEC that was established for the wildtype protein. Structural integrity of the mutant proteins was validated by analytical SEC, dynamic light scattering, heparin affinity chromatography (see below) and circular dichroism (CD) measurements.
For the overproduction and purification of McsB, mcsB from B. stearothermophilus was amplified using the primers GATGATCATATGTCGTTCGGGAAGTTTTTCAACAC and GATGATGTCGACTCGTTCATCACCCTCCATCTTTC, and subsequently cloned into the pET21a vector. Purification of the C-terminal His-tagged protein was performed by Ni-NTA chromatography applying the standard protocol and by SEC using a Superdex-200 column equilibrated with 150 mM NaCl, 20 mM Tris/HCl pH 8.0. McsB mutants were generated and verified using the same procedures described for CtsR mutants.
Electrophoretic mobility shift assays (EMSA)
For DNA-binding studies, 1 µM of CtsR was first incubated with 5 mM MgCl 2 , 1 mM ATP, 2% glycerol, 10 mM β-mercaptoethanol, 30 mM Tris pH 8.0 and 500 ng of the clpC promoter fragment (258 bp). The effect of McsB on the preformed CtsR/DNA complex was tested by adding various amounts of the kinase and incubating the reaction mixture for 30 minutes at 40°C. Kinase inhibition studies and dephosphorylation assays were conducted by applying either 20 mM EDTA or 2 μM calf intestinal phosphatase (New England Biolabs), respectively. DNA band shifts were visualized by ethidium bromide staining of the native 6% polyacrylamide gel and allowed differentiation of three DNA species (free DNA, CtsR 2 /DNA and CtsR 4 /DNA). A non-cognate DNA fragment was not shifted by CtsR, thus confirming specificity of CtsR for the analyzed direct repeat sequences.
Isolation of phosphorylated CtsR by heparin chromatography
After phosphorylating CtsR by McsB (buffer composition as in EMSA analysis, but with 2 mM ATP), the protein mixture was loaded on a heparin affinity column (GE Healthcare) equilibrated with 50 mM KCl, 30 mM KH 2 PO 4 pH 7.5. McsB, CtsR and CtsR-P could be efficiently separated by applying a salt gradient from 50 mM to 1 M KCl. Electrospray ionization (ESI) MS and CD measurements confirmed the identity and structural integrity of the individual protein samples.
Crystallization and structure solution of a CtsR 2 /DNA complex
The DNA oligonucleotides used for crystallization were manufactured by Sigma and VBC genomics. Prior to use, all oligonucleotides were further purified by reversed-phase chromatography. The DNA was hybridized by heating to 90°C for 5 min and subsequent slow-cooling to room temperature over 2 hours. The protein sample was mixed with dsDNA and concentrated with VIVASPIN concentrators (cutoff 10 kDa). From the 30 dsDNA oligonucleotides, which contained the ctsr box and different overhangs, tested in crystallization trials, only the oligonucleotide GATTAAGGTCAAATATAGTCAAAATA (CtsR consensus sites underlined) yielded protein/DNA crystals that diffracted beyond 3.0 Å resolution. The CtsR 2 /DNA crystals were grown with the sitting-drop vapour-diffusion method by mixing 2 µl of a protein/DNA solution (10 mg/ml CtsR 2 and an equimolar amount of the 26 bp DNA duplex) with 1 µl of a reservoir solution containing 220 mM ammonium sulfate, 20% PEG300, 15% glycerol and 100 mM phosphate/citrate buffer pH 4.2. The crystals belonged to the orthorhombic space group P2 1 2 1 2 1 (a = 63.198 Å, b = 76.087 Å, c = 167.568 Å) and contained one CtsR 2 /DNA complex per asymmetric unit. For cryo-protection, the crystals were transferred to a crystallization solution supplemented with 25% glycerol, and then flash frozen in liquid nitrogen. Single-wavelength anomalous dispersion data were collected at the Swiss Light Source (SLS, Beamline X06SA) at λ=0.9724 Å using a Pilatus detector (Dectris). Diffraction data were processed with MOSFLM (S1) and scaled with SCALA (S2). 15 out of 16 selenium sites of dimeric CtsR were immediately located with SnB (S3). Subsequent phasing conducted with SHARP (S4) and solvent flattening with SOLOMON (S5) yielded an electron density map of excellent quality ( Fig.S8 ) that allowed unambiguous tracing of CtsR and bound DNA. The structure was build and refined using the programs O (S6), COOT (S7) and CNS (S8) . All but the very C-and N-terminal residues were well-defined by electron density. The final structure was refined at 2.4 Å resolution to an R-factor of 21.3% (R free value of 25.9%) and exhibited good stereochemistry. 92% of the CtsR residues lie in the most favored region of the Ramachandran plot and only Tyr129 that was well-defined by electron density is located in the disallowed region. Data collection, phasing and refinement statistics are summarized in Table S1 . All figures illustrating molecular details were prepared with PyMOL (S9).
Isothermal titration calorimetry
Thermodynamic values of the interaction between CtsR (or CtsR-P) and dsDNA were determined by ITC (MCS-ITC; Microcal). All experiments were conducted in overflow mode at 30°C. 1.8 ml solution of CtsR (15 μM) was placed in the temperature-controlled sample cell and titrated with 26 bp dsDNA (50 µM; same DNA as used for crystallization) loaded in the 300 μl mixing syringe. For all experiments 300 mM KCl, 1 mM EDTA, 30 mM KH 2 PO 4 pH 7.5 was used as ITC buffer. After an initial injection of 2.5 μl, injections of 10 μl dsDNA were dispensed into the sample cell using a 120 s equilibration time between injections and stirring at 300 rpm. Control experiments were carried out in order to measure and correct the heat of dilution upon buffer addition. Finally, the data were analyzed using the program ORIGIN following the instructions of the manufacturer.
MS/MS methodology for the identification of protein arginine phosphorylation
To obtain phosphorylated protein for MS analysis, 20 μM of wildtype CtsR (or corresponding mutants, see below) were incubated with 20 μM McsB dissolved in 5 mM MgCl 2 , 1 mM ATP, 2% glycerol, 30 mM Tris pH 8.0. After 30 minutes at 40°C, the McsB/CtsR reaction mixture was diluted with 50 mM NH 4 HCO 3 to a protein concentration of 2 µM CtsR. Cysteine sidechains were alkylated with iodoacetamide and the protein solution digested with chymotrypsin (0.05 µM) for 4 hours. The cleavage reaction was stopped by freezing with liquid N 2 . Prior to HPLC-MS analysis, the resulting peptide mixture was diluted to 0.2 µM with 0.1% trifluoroacetic acid (TFA). Peptide separation was carried out on a nanoC18 column (Acclaim, 15 cm x 75 µm x 3 µm, 100 Å, Dionex) using the following solvent system: 5% acetonitrile, 0.1% formic acid (solvent A); 30% acetonitrile, 0.1% formic acid (solvent B); 80% acetonitrile, 0.08% formic acid, 10% trifluoroethanol (solvent C). A linear gradient from 100/0/0% A/B/C to 0/100/0% (86 min) was applied followed by two short linear gradients from 0/100/0% to 0/85/15% (4 min) and 0/85/15% to 0/10/90% C (5 min). The HPLC outlet was directly coupled to a nanoESI (Proxeon). The LTQ-FT mass spectrometer (ThermoFisher Scientific) was operated in positive ionization mode. The applied acquisition method consisted of a survey scan to detect individual peptide ions followed by six MS/MS experiments of the three most intense signals. For the analysis of individual peptide ions, two adjacent MS/MS experiments were conducted, one using multistage activation CAD MS/MS (S10) in the ion trap part of the instrument and the second with ECD (S11) in the Fouriertransform ion cyclotron resonance (FT-ICR) cell. Singly charged ions were rejected from MS/MS analysis. Since CAD-labile modifications such as phosphorylation of serine, threonine and histidine are not lost upon ECD activation, the combination of both fragmentations is superior to CAD analysis alone (S12).
MS data were searched with the MASCOT software against an in-house database consisting of approximately 700 entries of standard proteins and synthetic peptides. Utilized mass accuracies were 3 ppm for the precursor ion mass, 0.05 Da in case of ECD fragmentation and 0.5 Da for CAD fragmentation. All identified phospho-peptides of CtsR were validated manually on the basis of their MS/MS spectra.
Protein mass determination and top down experiments
After incubation with McsB (see above), wildtype and mutant CtsR samples had to be desalted prior to nanoESI MS analysis. Using strataX C18 tips (1 ml volume, Phenomenex), salts were removed by washing with 2 ml 0.1% TFA and subsequently, all bound CtsR species were eluted with 60% isopropanol, 30% methanol. Desalted proteins were acidified with formic acid (final concentration of 2%) and directly infused into the LTQ-FT mass spectrometer using static nano-electrospray conditions. Protein mass determination: Full scan data were acquired in a mass range from 700 to 1600 Da in the FT-ICR cell with a resolution set to 400,000 (at m/z 400). Mass-to-charge ratios were extracted from the raw data, deconvoluted and deisotoped with the Xtract software (Thermo-Fisher Scientific). Phosphorylation ratios of wildtype CtsR and the mutant proteins were determined from the signal intensities of the different phosphorylation states.
Top-down fragmentation analysis: The 25-fold charged, mono-phosphorylated CtsR ion at 766 m/z represented the most intense signal of CtsR-P and was subjected to ECD, CAD and IRMPD fragmentation. For optimal charge state assignment, fragment ion spectra were acquired at a resolution of 400,000 at m/z 400. Fragment ion signals were extracted with the ManualExtract software and correct assignment was reassessed manually prior to phosphorylation analysis with the ProSightPC software (Thermo-Fisher Scientific). To locate the site of modification, theoretical fragment ion patterns of all potential phosphorylated isoforms of CtsR-P were compared with the experimental dataset. The number of peptide fragments identified for a specific phospho-isoform directly correlates with the phosphorylation probability.
In vitro phosphorylation assay with synthetic peptides N-terminally acetylated peptides were synthesized in-house on a Syro Peptide Synthesizer (Multisyntech) and HPLC purified. Pure lyophylized peptides were dissolved in water to 1mg/ml. The 100 µl reaction assay contained 5 mM MgCl 2 , 1 mM ATP, 20 mM Tris pH 8.0, 15 µM McsB and 40 µM peptide. All reactions were carried out at 40°C for 3 hours. For matrix-assisted laser desorption/ionization (MALDI) MS analysis, reaction mixtures were 20-fold diluted with water. The MALDI matrix contained 2,5-dihydroxybenzoic acid (DHB), 80% acetonitrile, 0.2% H 3 PO 4 , and 1% TFA. MALDI measurements were carried out on a 4800 TOF/TOF Analyzer (Applied Biosystems) using an acquisition method optimized for the DHB matrix. After calibration with standard phospho-peptides, 5000 scans were acquired per sample spot to warrant valid statistics for semi-quantification. Signal areas and intensities were extracted with the Data Explorer software (Applied Biosystems). Ratios of the peak areas of phosphorylated and unphosphorylated peptides were computed for each peptide individually. All ratios were standardized to the phosphorylation efficiency of the peptide K 61 RGGGGYIKIIKV 73 .
P NMR spectroscopy
To acquire 31 P-NMR spectra of phospho-arginine in a peptide context, we first incubated K 61 RGGGGYIKIIKV 73 with McsB. Modified and unmodified peptides were separated by HPLC with a Jupiter C18 column (Phenomenex; solvent A: 10 mM methylphosphonate pH 7.0; solvent B: 60% acetonitrile, 10% trifluoroethanol and 10 mM methylphosphonate pH 7.0) using a linear gradient from 10% to 40% of solvent B. Fractions containing the phosphopeptide were lyophylized to remove organic solvents. Buffer salts were removed by solid phase extraction (SPE). The McsB-phosphorylated peptide was dissolved in 50 mM ammonium heptafluorobutyrate, pH 6, and slowly loaded onto preconstituted Strata-X SPE columns (C 18 material, Phenomenex). To remove impurities, 1 ml of the loading solvent and 1ml of H 2 O were rinsed through the columns rapidly. Bound peptides were eluted with 60% ACN and subsequently lyophylized. N-terminally acetylated phospho-peptides K 61 pYGGGGYIKIIKV 73 and K 61 pSGGGGYIKIIKV 73 were synthesized in-house on a Syro Peptide Synthesizer (Multisyntech) and HPLC purified. Prior to NMR measurements the lyophilized phospho-peptide-samples were dissolved in 0.6 ml D 2 O. 31 P-NMR spectra were acquired on an Avance DRX-600 NMR spectrometer (Bruker) at 25°C with a phosphorus specific instrument method allowing proton decoupling. The excitation frequency for phosphorus was 242.9367770 MHz.
Thermal stability of phospho-arginine in peptides
The peptide K 61 RGGGGYIKIIKV 73 was phosphorylated by McsB with subsequent HPLC purification at neutral pH as described previously. The lyophylized peptide was dissolved in water. A 200 mM ammonium phosphate buffer with pH adjusted to 7 was prepared and preheated for experiments at elevated temperatures (60°C, 95°C). The peptide was added to the buffer to a final concentration of 20 µM. Aliquots were taken after 5, 15, 30, 60, 120 and 240 minutes, frozen in liquid nitrogen and analyzed by HPLC-MS as described previously. Eluting peptides were directly detected by UV absorption at 214 nm and coupled MS analysis (LCQ-XP, Thermo-Fisher Scientific). Finally, the UV 214 peak area of modified and unmodified peptides and the respective signal areas in the extracted ion chromatograms (2+ and 3+ charged) were used for quantification of phospho-arginine hydrolysis.
SUPPLEMENTARY FIGURES
Fig.S1 CAD MS/MS spectrum of the phospho-peptide I 57 VESKpRGGGGYIRIM 71
(A) FT-ICR mass spectrum of the phospho-arginine containing peptide 57-71. The spectrum includes the doubly charged ion of I 57 VESKpRGGGGYIRIM 71 (858.4385 m/z) that was subjected to CAD fragmentation. (B) The resulting CAD MS/MS spectrum clearly shows the loss of phosphoric acid from the doubly charged precursor ion (858.4385 m/z) yielding an ion with a mass of 810 m/z. This fragmentation behavior is commonly associated with CAD labile phospho-sites such as serine, threonine and histidine.
Fig.S2 ECD MS/MS spectra of Arg49 and Arg28 containing phospho-peptides
(A) The ECD fragment ion spectrum of phosphorylated V 45 INTpRF 50 . Both c-and z-fragment ion series revealed that Arg49 is phosphorylated, whereas the other potential phospho-site, Thr48, is unmodified. Due to the fragmentation behavior of two-fold charged ions, the signals of fragments were present at low intensity. Fragments that enclose the phosphorylated arginine residue are highlighted in red. (B) ECD MS/MS spectrum of the phospho-peptide L 12 KQVLNMSDQDIVEIKpRSEIANKF 35 (mass range 150-2000 m/z). In the spectrum, the entire c-type fragment ion series is labelled, whereas in the z-ion series only the two fragments defining the phosphorylation site are marked.
Fig.S3 Major groove interactions originating from the HTH motif
(A) Atomic model of how the recognition helix (the second helix) of the HTH motif, intercalates into the DNA major groove. For clarity, only the side chains of the main interacting residues Val38, Ser40, Tyr44 and Arg49 are shown in stick representation. Carbon atoms of protein and DNA are colored orange and green, respectively. (B) Protein backbone of the N-terminal half of the first helix of the HTH motif with its positive macrodipole directed against the phosphate group of G3. In addition, the guanidinium group of the conserved Arg28 hydrogen-bonds to the purine-specific nitrogen (N7) of nucleotides G3 and G4.
Fig.S4 McsB preferentially targets free CtsR over DNA-bound CtsR
To test the ability of McsB to phosphorylate CtsR bound to DNA (clpC promoter), a preformed CtsR/DNA complex was incubated with McsB and the reaction stopped with EDTA at the indicated time points (lanes 3-6). CtsR/DNA complexes were monitored by DNA band-shift assays. To evaluate the ability of targeting free CtsR, McsB was incubated with CtsR alone for various times (lanes 7-10) and the phosphorylation reaction was stopped with EDTA. After addition of DNA, band-shift assays revealed a significantly reduced potential of CtsR to bind to its target sequence. The purified phospho-peptide K 61 pRGGGGYIKIIKV 73 was incubated under physiological pH conditions (pH 7) at different temperatures and assayed for phospho-stability. Samples were taken at the indicated time points and analyzed by HPLC/MS to quantify phosphorylated and de-phosphorylated peptide species. Solid lines represent the fraction of phosphorylated peptide, dashed lines the fraction of de-phosphorylated peptides (25°C, black; 60°C, magenta; 95°C, red). Sequence alignment of McsB with arginine kinase from Limulus polyphemus and creatine kinase from Torpedo californica (using T-COFFEE (S16)). Mechanistic important residues shown in (A) are highlighted in yellow. Note that all residues essential for the direct in-line phopho-transfer from ATP to the substrate's guanidinium group are entirely conserved. Identical residues are colored in dark grey whereas homologous residues are shaded in light grey. The highly conserved phosphagen kinase specific NEED motif is boxed. (C) The residue in position 314 is a main determinant of substrate specificity and strikingly differs between arginine kinase (Glu314) and creatine kinase (Val325). In McsB orthologs, a glutamate residue (Glu213) is strictly conserved in this position arguing for a highly specific accommodation of a guanidinium group. The other mutated McsB residues Glu122 is homologous to the arginine kinase residue Glu225. (D) The pronounced homology in the catalytic domains of McsB and PhKs prompted us to examine the functional conservation of active site residues implicated in arginine phosphorylation. To this end, we mutated two glutamate residues that have been shown to fix the substrate's guanidinium group in proper position for efficient phospho-transfer (S14). The generated E122A and E213A McsB mutants exhibited the same physico-chemical properties as the wildtype enzyme, but failed to inhibit CtsR/DNA association in EMSA experiments (lane 4 and 5). Therefore both mutants appear to be catalytically impaired in promoting arginine phosphorylation. Consistently, the E112A and E213A mutants did not show kinase activity in our peptide phosphorylation assay.
Since McsB does not contain the N-terminal domain of PhKs associated with substrate binding (S17), we next generated a McsB deletion mutant lacking its unique C-terminal domain. Removal of this domain abolished the kinase activity of McsB against CtsR (lane 6). Thus, the C-terminal domain seems to be of general importance for the function of McsB and may either stabilize the catalytic domain in its active conformation or mediate the tethering of peptidic substrates for efficient phospho-transfer.
Fig.S8 Stereo view of the electron density of the β-hairpin wing
The SAD-phased electron density map calculated at 2.4 Å resolution and contoured at 1.2σ is shown together with residues 57-71 of the refined CtsR/DNA structure. Phasing power is the root mean squared value of F H divided by the root mean squared lackof-closure. 4 R cryst = Σ hkl | |F obs (hkl)| -k |F calc (hkl)| | / Σ hkl |F obs (hkl)| for the working set of reflections; R free is the R-value for 5% of the reflections excluded from refinement.
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The stereochemistry of the model was validated with PROCHECK (S18).
